Low-Dose ATG Based GVHD Prophylaxis Regimens Provide Similar Outcomes When Compared to Post-Transplant Cyclophosphamide Based Regimens after Allogeneic Stem Cell Transplantation Using HLA Mismatched Unrelated Donors

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Ali Alkhars, Sarah Samarkandi, David Allan, Harold L. Atkins, Christopher Bredeson, Natasha K. Kekre, Michael Kennah, Ashish Narayan Masurekar, Santhosh Thyagu, Ram Vasudevan Nampoothiri
DOI: 10.1016/j.jtct.2025.12.374
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S262–S263
Publication date
1 February 2026
Language
EN